Literature DB >> 2393283

Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.

R H Barbhaiya1, U A Shukla, C R Gleason, W C Shyu, K A Pittman.   

Abstract

The objective of this study was to assess the effects of food on the pharmacokinetics of cefprozil and cefaclor. A group of 12 healthy male volunteers received a single 250-mg dose of cefprozil or cefaclor under fasting conditions as well as after the intake of food. There was a 1-week washout period between each treatment. Serial blood samples were collected and assayed for cefprozil or cefaclor by specific high-pressure liquid chromatographic methods. The mean +/- standard deviation peak concentration (Cmax) of cefprozil in plasma was 6.13 +/- 1.22 micrograms/ml under the fasting condition and 5.27 +/- 1.06 micrograms/ml after breakfast, and these values were not significantly different from each other. The corresponding median time to reach Cmax was prolonged after food intake, but this difference was not significant. The mean Cmax values of cefaclor decreased significantly from 8.70 +/- 2.72 micrograms/ml under the fasting condition to 4.29 +/- 1.52 micrograms/ml after breakfast, and the corresponding median times to reach Cmax were significantly prolonged. The mean half-lives of cefprozil and cefaclor were nearly identical for the two treatments, suggesting that the elimination kinetics of these cephalosporins remained unaltered when the drugs were administered with food. The area under the plasma-concentration-versus-time curves for fasted and fed conditions were not significantly different for both drugs. The results of this study indicate that the extent of absorption and rate of elimination of both cephalosporins remain unaltered in the presence of food. However, the absorption rate of cefaclor is significantly reduced in the presence of food, while that of cefprozil remains unaltered. As a result, the Cmax of cefaclor is significantly reduced in the presence of food, whereas that of cefprozil is not significantly affected. Cefprozil can be administered with a meal without markedly affecting levels in blood.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393283      PMCID: PMC171786          DOI: 10.1128/AAC.34.6.1210

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Evaluation of effect of food ingestion on bioavailability of cephalexin by moment analysis.

Authors:  J Haginaka; K Yamaoka; T Nakagawa; Y Nishimura; T Uno
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-12       Impact factor: 1.645

3.  A human pharmacology study of cefaclor.

Authors:  A Glynne; R A Goulbourn; R Ryden
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

Review 4.  The influence of food on the absorption of antimicrobial agents.

Authors:  P G Welling; F L Tse
Journal:  J Antimicrob Chemother       Date:  1982-01       Impact factor: 5.790

5.  The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

Authors:  S Riegelman; P Collier
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

6.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.

Authors:  P G Welling; S Dean; A Selen; M J Kendall; R Wise
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-09

8.  Cephradine absorption and excretion in fasting and nonfasting volunteers.

Authors:  C Harvengt; P De Schepper; F Lamy; J Hansen
Journal:  J Clin Pharmacol New Drugs       Date:  1973-01

9.  Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability.

Authors:  G H McCracken; C M Ginsburg; J C Clahsen; M L Thomas
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

10.  Pharmacological evaluation of cefaclor in volunteers.

Authors:  G R Hodges; C Liu; D R Hinthorn; J L Harms; D L Dworzack
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

View more
  20 in total

1.  The effect of four different types of food on the bioavailability of cefaclor.

Authors:  S Karim; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jul-Sep       Impact factor: 2.441

2.  Comparative effect of different types of food on the bioavailability of cefaclor extended release tablet.

Authors:  B A H Khan; T Ahmed; S Karim; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

3.  Pharmacokinetics of cefprozil in infants and children.

Authors:  X Sáez-Llorens; W C Shyu; S Shelton; H Kumiesz; J Nelson
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

4.  The effect of four different types of diet on the bioavailability of loracarbef.

Authors:  A T Bapujee; T Singh; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

5.  Phase I study of multiple-dose cefprozil and comparison with cefaclor.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 7.  Comparative pharmacokinetics of the new oral cephalosporins.

Authors:  H Lode; M Fassbender; T Schaberg; K Borner; P Koeppe
Journal:  Drugs       Date:  1994       Impact factor: 9.546

Review 8.  Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.

Authors:  L R Wiseman; P Benfield
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

Review 9.  Clinical pharmacokinetics of newer cephalosporins.

Authors:  M E Klepser; M N Marangos; K B Patel; D P Nicolau; R Quintiliani; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 10.  Cefprozil: a review.

Authors:  Sumit Bhargava; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2003-05       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.